Primary Antibodies
- Trastuzumab (anti-ERBB2)Associated targets: ERBB2Cas#: 180288-69-1 Compound CID: 135518164Formula: C6470H10012N1726O2013S42 Molecular Weight: 145531.50IUPAC Name: 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-oneSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2N)O)O)OInChIKey: FNXPTCITVCRFRK-UMMCILCDSA-NInChI: InChI=1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1Synonyms: 8-Aminoguanosine, >=98% (HPLC) | SHO2CA1BRO | Guanosine, 8-amino- | SCHEMBL483333 | 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-...
- Bevacizumab (anti-VEGF)Associated targets: VEGFACas#: 216974-75-3Formula: Molecular Weight: 149 kDa(Average)
- Alirocumab (anti-PCSK9)Associated targets: PCSK9Cas#: 1245916-14-6SMILES: C(C(COP(=O)(O)O)O)O.[Na].[Na]InChIKey: CATWCRUATKKAAQ-UHFFFAOYSA-NInChI: InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;Synonyms: BCP25199 | CID 88214187 | 1245916-14-6 | B0084-007210 | SCHEMBL7870957 | BA165582
- TGF beta Mouse mAbSpecies reactivity(Reacts with): Cow,Dog,Hamster,Human,Monkey,Mouse,RatHost species: Mouse Isotype: Mouse IgG1Synonyms: Cartilage-inducing factor antibody | CED antibody | Differentiation inhibiting factor antibody | DPD1 antibody | LAP ...
- Recombinant IFNγ AntibodyAssociated targets: IFNGSpecies reactivity(Reacts with): MouseHost species: Rat Isotype: Rat IgG1Synonyms: Ifg | If2f | IFN-g | IFI | IFNG | IFNgamma | IFN-gamma | Immune interferon | interferon gamma | interferon, gamma | I...
- CD25 Rat mAbAssociated targets: IL2RASpecies reactivity(Reacts with): MouseHost species: Rat Isotype: Rat IgG1Synonyms: CD25 Rat mAb | CD25, Il2r, Ly-43 | Interleukin 2 receptor alpha chain antibody | CD25 antibody | CD25 antigen antibod...
- Atezolizumab (anti-PD-L1), INHIBITOR of Programmed cell death 1 ligand 1 inhibitorAssociated targets: CD274Species reactivity(Reacts with): HumanCas#: 1380723-44-3 Compound CID: 168009942SMILES: CC.CCCC(=NC(CC=C)C1=CC(=C(C=C1)N)S)C=C(C(=O)N(CCC(C)CC)C(C)CC)N.CC=CC(=CC)C(=O)CSynonyms: MPDL3280A
- Camrelizumab (anti-PD-1), ANTAGONIST of Programmed cell death protein 1 antagonistAssociated targets: PDCD1Species reactivity(Reacts with): Cynomolgus monkey,HumanHost species: Human Isotype: Human IgG4SPCas#: 1798286-48-2Synonyms: SHR-1210 | CD279 antigen | CD279 | hPD-1 | PD1 | PD-1 | PD1hPD-l | PDCD1 | programmed cell death 1 | programmed cell ...
- Cetuximab (anti-EGFR)Associated targets: EGFRSpecies reactivity(Reacts with): Cynomolgus monkey,HumanCas#: 205923-56-4Formula: Molecular Weight: 145543.35
- Nivolumab (anti-PD-1), Antibody of programmed cell death 1 (CD279)Associated targets: PDCD1Species reactivity(Reacts with): Cynomolgus monkey,HumanHost species: Human Isotype: Human IgG4SPCas#: 946414-94-4 Compound CID: 168009888IUPAC Name: 3-methyl-5-methylsulfonyl-1-(2,2,4-trimethyl-3,4-dihydro-1H-quinolin-8-yl)pent-4-en-1-one;3-methyl-5-methylsulfonyl-1-(2,2,4-trimethyl-1H-quinolin-8-yl)pent-4-en-1-one;5-methylsulfonyl-1-(2,2,4-trimethyl-3,4-dihydro-1H-quinolin-8-yl)pent-4-en-1-one;5-methylsulfonyl-1-(2,2,4-trimethyl-1H-quinolin-8-yl)pent-4-en-1-oneSMILES: CC1CC(NC2=C1C=CC=C2C(=O)CCC=CS(=O)(=O)C)(C)C.CC1CC(NC2=C1C=CC=C2C(=O)CC(C)C=CS(=O)(=O)C)(C)C.CC1=CC(NC2=C1C=CC=C2C(=O)CCC=CS(=O)(=O)C)(C)C.CC1=CC(NC2=C1C=CC=C2C(=O)CC(C)C=CS(=O)(=O)C)(C)CInChIKey: VSTHRBNUEGPUOM-UHFFFAOYSA-NInChI: InChI=1S/C19H27NO3S.C19H25NO3S.C18H25NO3S.C18H23NO3S/c2*1-13(9-10-24(5,22)23)11-17(21)16-8-6-7-15-14(2)12-19(3,4)20-18(15)16;2*1-13-12-18(2,3)19-17-14(13)8-7-9-15(17)16(20)10-5-6-11-23(4,21)22/h6-10,13-14,20H,11-12H2,1-5H3;6-10,12-13,20H,11H2,1-5H3;6-9,11,13,19H,5,10,12H2,1-4H3;6-9,11-12,19H,5,10H2,1-4H3Synonyms: CID 167682467 | hPD-1 | Protein PD-1
- Rituximab (anti-CD20), BINDING AGENT of B-lymphocyte antigen CD20 binding agentAssociated targets: MS4A1Species reactivity(Reacts with): HumanCas#: 174722-31-7 Compound CID: 168009840SMILES: CC=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)N=CC4)C(=O)C5CCCCC5.CC=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)N=C(O4)C)C(=O)C5CCCCC5.COC(=O)C=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)NCCO4)C(=O)C5CCCCC5.COC(=O)C=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)OCCO4)C(=O)C5CCCCC5.COC(=O)C=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)NCCS4)C(=O)C5CCCCC5.COC(=O)C=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)NCCS4(=O)=O)C(=O)C5CCCCC5.COC(=O)C=CC1=CC(=CC=C1)N(CC2=CC=C(C=C2)C3=CC4=NC=CN=C4C=C3)C(=O)C5CCCCC5